보로노이

310210KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

118,800KRWMarket close of 10/27 (Tue)

Down -2.86%-3,500KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)121,100KRWUp +1.94%

Preliminary · replaced once official KRX data for the same date is published

Open
124,700
High
127,000
Low
115,900
Day range
Day range low 115,900 high 127,000, open 124,700, close 118,800, previous close 122,300
Volume
7×10K shares
8.9B KRW 0.96× the 20-session average

Market close of 10/27 (Tue)

Where it sits in the 1-year range

1-year close range 100,800 to 363,500 won, 7% up from the low

7% of the way up from the lowest close in 1 year (252 sessions) · -67.3% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Earningsto check-81.0B KRWOperating income over the last four quarters -81.0B KRW (loss)Operating income, 8 quarters
  • Foreign & institutionalto check-1.9B KRW5 sessions: foreign -0.6B KRW · institutional -1.3B KRW
    Last 5 sessions: foreigners -600.00 million KRW · institutions -1.3B KRW
  • Recent filingsnot verifiedCould not read filing data, so not verified

The other 2 are within the usual range

  • Daily move-2.86%usual range
  • Trading value1.0×usual range
See the full check report

Same sector · 바이오 R&D

Down -0.67%

· 26 of 64 stocks up, preferred shares excluded · trading value 190.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -12.6%Flat 0.00%51.8B KRW
올릭스Close over the last 20 sessions -11.8%Down -5.72%24.1B KRW
디앤디파마텍Close over the last 20 sessions -8.3%Up +0.37%14.0B KRW
리가켐바이오Close over the last 20 sessions -20.9%Down -1.54%12.1B KRW
페니트리움바이오Close over the last 20 sessions -4.2%Up +14.41%9.8B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 19 days
  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.